Ian Frazer
#5,575
Most Influential Person Now
British–Australian scientist
Ian Frazer's AcademicInfluence.com Rankings
Ian Frazerbiology Degrees
Biology
#549
World Rank
#968
Historical Rank
Immunology
#59
World Rank
#65
Historical Rank
Ian Frazerphilosophy Degrees
Philosophy
#4505
World Rank
#7046
Historical Rank
Logic
#4326
World Rank
#5601
Historical Rank
Download Badge
Biology Philosophy
Why Is Ian Frazer Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ian Hector Frazer is a Scottish-born Australian immunologist, the founding CEO and Director of Research of the Translational Research Institute . Frazer and Jian Zhou developed and patented the basic technology behind the HPV vaccine against cervical cancer at the University of Queensland. Researchers at the National Cancer Institute, Georgetown University, and University of Rochester also contributed to the further development of the cervical cancer vaccine in parallel.
Ian Frazer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. (1991) (549)
- New gene functions in megakaryopoiesis and platelet formation (2011) (423)
- Identification of the alpha6 integrin as a candidate receptor for papillomaviruses (1997) (404)
- Prevention of cervical cancer through papillomavirus vaccination (2004) (380)
- Chapter 12: Prophylactic HPV vaccines: underlying mechanisms. (2006) (267)
- Common variants in TMPRSS6 are associated with iron status and erythrocyte volume (2009) (254)
- Papillomavirus Capsid Protein Expression Level Depends on the Match between Codon Usage and tRNA Availability (1999) (246)
- Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity (2017) (243)
- The projected timeframe until cervical cancer elimination in Australia: a modelling study. (2018) (235)
- ASSOCIATION BETWEEN ANORECTAL DYSPLASIA, HUMAN PAPILLOMAVIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HOMOSEXUAL MEN (1986) (198)
- Genetic and environmental causes of variation in basal levels of blood cells (1999) (196)
- Interaction of human papillomaviruses with the host immune system: a well evolved relationship. (2009) (188)
- HPV6b virus like particles are potent immunogens without adjuvant in man. (2000) (182)
- Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia. (2004) (179)
- A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. (1991) (175)
- Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. (2009) (175)
- Papillomavirus capsid binding and uptake by cells from different tissues and species (1995) (172)
- Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. (2010) (164)
- Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell. (2002) (161)
- Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model (2010) (159)
- Cervical cancer control, priorities and new directions (2004) (141)
- Screening to prevent cervical cancer: Guidelines for the management of asymptomatic women with screen detected abnormalities (2005) (132)
- Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. (1998) (130)
- Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence (1994) (127)
- Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. (1992) (126)
- Advances in Prevention of Cervical Cancer and Other Human Papillomavirus-Related Diseases (2006) (125)
- Synthesis and assembly of infectious bovine papillomavirus particles in vitro. (1993) (124)
- Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. (1999) (122)
- Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens. (1985) (120)
- Consensus nomenclature for CD8+ T cell phenotypes in cancer (2015) (118)
- Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization. (2011) (118)
- Immunology of papillomavirus infection. (1996) (112)
- Potential strategies utilised by papillomavirus to evade host immunity (1999) (109)
- Skin Vaccination against Cervical Cancer Associated Human Papillomavirus with a Novel Micro-Projection Array in a Mouse Model (2010) (109)
- Prevention and treatment of papillomavirus-related cancers through immunization. (2011) (104)
- Development of therapeutic HPV vaccines. (2009) (99)
- Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. (2002) (97)
- Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice. (1998) (93)
- Sequence variants in three loci influence monocyte counts and erythrocyte volume. (2009) (87)
- Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. (2012) (87)
- Human aortic valve allografts elicit a donor-specific immune response. (1996) (86)
- Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System (2019) (85)
- Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. (2001) (83)
- Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control. (2010) (83)
- Co-localization of cell death with antigen deposition in skin enhances vaccine immunogenicity (2014) (81)
- Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins. (2000) (80)
- DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1. (1998) (80)
- Defining the genetic susceptibility to cervical neoplasia—A genome-wide association study (2017) (78)
- Codon usage bias and A+T content variation in human papillomavirus genomes. (2003) (78)
- Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein. (1991) (77)
- Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™). (2018) (77)
- Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. (1996) (76)
- Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference (2001) (76)
- HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. (2005) (75)
- Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation. (1994) (73)
- Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes. (2000) (72)
- Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells. (2004) (71)
- Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies (2020) (71)
- Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors. (2004) (70)
- Role of Ultraviolet Radiation in Papillomavirus-Induced Disease (2016) (68)
- Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model. (1998) (67)
- Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal. (1997) (67)
- Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques. (2002) (66)
- Chapter 16: Prophylactic human papillomavirus vaccines. (2003) (64)
- Transmission of Human Papillomaviruses from Mother to Child (1993) (64)
- Regulation of immune responses to HPVinfection and during HPV‐directed immunotherapy (2011) (64)
- Correlating immunity with protection for HPV infection. (2007) (62)
- Gene Codon Composition Determines Differentiation-Dependent Expression of a Viral Capsid Gene in Keratinocytes In Vitro and InVivo (2005) (61)
- Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. (1990) (61)
- Invariant NKT Cells in Hyperplastic Skin Induce a Local Immune Suppressive Environment by IFN-γ Production (2009) (61)
- A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16INK4a expression in head and neck squamous cell carcinoma patients (2016) (61)
- HPV16-E7 Expression in Squamous Epithelium Creates a Local Immune Suppressive Environment via CCL2- and CCL5- Mediated Recruitment of Mast Cells (2014) (60)
- Activation of dendritic cells by human papillomavirus‐like particles through TLR4 and NF‐κB‐mediated signalling, moderated by TGF‐β (2005) (59)
- The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion. (1992) (58)
- Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles. (1992) (58)
- Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. (1994) (58)
- IL-17 Suppresses Immune Effector Functions in Human Papillomavirus-Associated Epithelial Hyperplasia (2014) (57)
- Measuring serum antibody to human papillomavirus following infection or vaccination. (2010) (57)
- Prevention of cancer through immunization: Prospects and challenges for the 21st century (2007) (54)
- Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein. (1996) (53)
- The number of long‐lasting functional memory CD8+ T cells generated depends on the nature of the initial nonspecific stimulation (2002) (53)
- Tolerance or Immunity to a Tumor Antigen Expressed in Somatic Cells Can Be Determined by Systemic Proinflammatory Signals at the Time of First Antigen Exposure1 (2001) (52)
- Assessment of delayed-type hypersensitivity in man: a comparison of the "Multitest" and conventional intradermal injection of six antigens. (1985) (50)
- Inhibition of early tumor growth requires Jα18-positive (natural killer T) cells (2003) (50)
- BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions. (2000) (49)
- IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host1 (2003) (48)
- A Novel DNA Vaccine Technology Conveying Protection against a Lethal Herpes Simplex Viral Challenge in Mice (2013) (48)
- Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease. (1995) (46)
- Donor-specific immune response after aortic valve allografting in the rat. (1994) (46)
- New Approaches to Immunotherapy for HPV Associated Cancers (2011) (45)
- Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes (1998) (45)
- Development and Implementation of Papillomavirus Prophylactic Vaccines (2014) (44)
- E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes (2000) (44)
- Major population differences in T cell response to a malaria sporozoite vaccine candidate. (1990) (44)
- ISCOMATRIX adjuvant: an adjuvant suitable for use in anticancer vaccines. (2004) (43)
- Modulation of antigen presenting cell functions during chronic HPV infection (2017) (43)
- HPV vaccines: the beginning of the end for cervical cancer. (2007) (43)
- Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses. (1993) (41)
- Does the nature of residual immune function explain the differential risk of non‐melanoma skin cancer development in immunosuppressed organ transplant recipients? (2016) (40)
- Comparative Immune Phenotypic Analysis of Cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in Immune-Competent Individuals: Proportional Representation of CD8+ T-Cells but Not FoxP3+ Regulatory T-Cells Is Associated with Disease Stage (2014) (40)
- Mutations in TAP genes are common in cervical carcinomas. (2004) (40)
- IFN-γ Promotes Generation of IL-10 Secreting CD4+ T Cells that Suppress Generation of CD8 Responses in an Antigen-Experienced Host1 (2009) (40)
- DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection (2017) (40)
- Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines. (1994) (40)
- Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T‐cell suppression mediated by CD4+CD25+ T cells (2009) (40)
- Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production. (1995) (39)
- A Pilot Study into the Association between Oral Health Status and Human Papillomavirus—16 Infection (2017) (38)
- NKT Cells Inhibit Antigen-Specific Effector CD8 T Cell Induction to Skin Viral Proteins (2011) (38)
- Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-kappaB-mediated signalling, moderated by TGF-beta. (2005) (37)
- Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein. (1995) (37)
- IL10 and IL12B polymorphisms each influence IL‐12p70 secretion by dendritic cells in response to LPS (2006) (36)
- tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes. (2004) (36)
- Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin. (2012) (36)
- Overcoming Original Antigenic Sin to Generate New CD8 T Cell IFN-γ Responses in an Antigen-Experienced Host1 (2006) (36)
- Vaccines for papillomavirus infection. (2002) (36)
- Replication of Bovine Papillomavirus Type 1 (BPV-1) DNA in Saccharomyces cerevisiae following Infection with BPV-1 Virions (2002) (35)
- Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study (2016) (34)
- Absence of autoimmune serological reactions in chronic non A, non B viral hepatitis. (1985) (33)
- Association of bovine papillomavirus type 1 with microtubules. (2001) (33)
- Major quantitative trait locus for eosinophil count is located on chromosome 2q. (2004) (33)
- Secretion of IFN-γ but Not IL-17 by CD1d-Restricted NKT Cells Enhances Rejection of Skin Grafts Expressing Epithelial Cell-Derived Antigen (2010) (33)
- IL-18, but not IL-12, induces production of IFN-γ in the immunosuppressive environment of HPV16 E7 transgenic hyperplastic skin (2014) (32)
- Route of administration of chimeric BPV1 VLP determines the character of the induced immune responses (2002) (32)
- Recombinant Wnt3a and Wnt5a elicit macrophage cytokine production and tolerization to microbial stimulation via Toll‐like receptor 4 (2014) (32)
- Histologic and immunohistochemical responses after aortic valve allografts in the rat. (1998) (31)
- Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH. (1983) (31)
- RNA-seq reveals more consistent reference genes for gene expression studies in human non-melanoma skin cancers (2017) (30)
- CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array. (2014) (30)
- Expression of a Single, Viral Oncoprotein in Skin Epithelium Is Sufficient to Recruit Lymphocytes (2013) (30)
- Interferon‐gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide (2002) (30)
- Intramuscular versus low‐dose intradermal hepatitis B vaccine: Assessment by humoral and cellular immune response to hepatitis B surface antigen (1987) (29)
- Randomized Placebo-Controlled Double-Blind Combined Therapy with Laser-Surgery and Systemic Interferon-Alpha-2A in the Treatment of Anogenital Condylomata Acuminatum (1993) (29)
- Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years. (1986) (29)
- Human papillomavirus 16 E7 protein inhibits interferon‐γ‐mediated enhancement of keratinocyte antigen processing and T‐cell lysis (2011) (28)
- Combined therapy trial with interferon alpha-2a and ablative therapy in the treatment of anogenital warts. (1996) (28)
- Saccharomyces cerevisiae Is Permissive for Replication of Bovine Papillomavirus Type 1 (2002) (28)
- Human papillomavirus — a study of male sexual partners (1988) (27)
- Microprojection arrays to immunise at mucosal surfaces. (2014) (27)
- The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN conference. (2008) (26)
- A major quantitative trait locus for CD4–CD8 ratio is located on chromosome 11 (2004) (26)
- T lymphocyte subpopulations defined by two sets of monoclonal antibodies in chronic active hepatitis and systemic lupus erythematosus. (1982) (26)
- Unlocking the Potential of Saliva-Based Test to Detect HPV-16-Driven Oropharyngeal Cancer (2019) (26)
- A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes (2018) (26)
- The role of vaccines in the control of STDs: HPV vaccines. (1996) (26)
- Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16 (2003) (26)
- LPAR1 and ITGA4 regulate peripheral blood monocyte counts (2011) (25)
- Differences in the post‐translational modifications of human papillomavirus type 6b major capsid protein expressed from a baculovirus system compared with a vaccinia virus system (2000) (25)
- Cell mediated immunity to papillomaviruses (1999) (25)
- Nuclear RelB+ cells are found in normal lymphoid organs and in peripheral tissue in the context of inflammation, but not under normal resting conditions (2002) (25)
- The cellular infiltrate in the liver in auto-immune chronic active hepatitis: analysis with monoclonal antibodies. (2008) (25)
- IL-10 Mediates Suppression of the CD8 T Cell IFN-γ. Response to a Novel Viral Epitope in a Primed Host (2004) (25)
- Human papillomavirus infection among head and neck squamous cell carcinomas in southern China (2019) (25)
- Association of clinical, radiological and synovial immunopathological responses to anti-rheumatic treatment in rheumatoid arthritis. (2001) (25)
- Impact of Sex Steroid Ablation on Viral, Tumour and Vaccine Responses in Aged Mice (2012) (25)
- Langerhans Cell Homeostasis and Activation Is Altered in Hyperplastic Human Papillomavirus Type 16 E7 Expressing Epidermis (2015) (25)
- E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein. (1997) (25)
- LONG-TERM EFFICACY OF FENFLURAMINE IN TREATMENT OF OBESITY (1983) (24)
- Evaluation of a Cervical Cancer Screening Program Based on HPV Testing and LLETZ Excision in a Low Resource Setting (2010) (24)
- Immunotherapy for HPV associated cancer (2019) (24)
- Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity (2016) (23)
- Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial (2019) (23)
- The overexpression of salivary cytokeratins as potential diagnostic biomarkers in head and neck squamous cell carcinomas (2017) (23)
- Generalized substitution of isoencoding codons shortens the duration of papillomavirus L1 protein expression in transiently gene-transfected keratinocytes due to cell differentiation (2007) (23)
- A Mouse Model of Hyperproliferative Human Epithelium Validated by Keratin Profiling Shows an Aberrant Cytoskeletal Response to Injury (2016) (23)
- The current status of development of prophylactic vaccines against Human Papillomavirus infection (1999) (23)
- An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1 (2016) (23)
- God's gift to women: the human papillomavirus vaccine. (2006) (22)
- Multivariate QTL linkage analysis suggests a QTL for platelet count on chromosome 19q (2004) (22)
- Nonspecific Down-Regulation of CD8+T-Cell Responses in Mice Expressing Human Papillomavirus Type 16 E7 Oncoprotein from the Keratin-14 Promoter (2001) (22)
- Antibody to liver membrane antigens in chronic active hepatitis. IV. Exclusion of specific reactivity to polypeptides and glycolipids by immunoblotting (1987) (22)
- Inhibition of early tumor growth requires J alpha 18-positive (natural killer T) cells. (2003) (21)
- Type specific and genotype cross reactive B epitopes of the L1 protein of HPV16 defined by a panel of monoclonal antibodies. (1998) (21)
- Oral HPV16 Prevalence in Oral Potentially Malignant Disorders and Oral Cavity Cancers (2020) (21)
- γδ T cells augment rejection of skin grafts by enhancing cross priming of CD8 T cells to skin derived antigen (2012) (21)
- HPV vaccines and the prevention of cervical cancer (2008) (21)
- Human papollomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction (1994) (21)
- Glycosylation of human papillomavirus type 16 L1 protein. (1993) (20)
- TLR7 stimulation augments T effector‐mediated rejection of skin expressing neo‐self antigen in keratinocytes (2008) (20)
- T-helper epitopes of the E7 transforming protein of cervical cancer associated human papillomavirus type 18 (HPV18). (1995) (20)
- Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions (2021) (20)
- Nucleotides 1506-1625 of bovine papillomavirus type 1 genome can enhance DNA packaging by L1/L2 capsids. (1999) (20)
- Microprojection arrays applied to skin generate mechanical stress, induce an inflammatory transcriptome and cell death, and improve vaccine-induced immune responses (2019) (19)
- HLA and KIR Associations of Cervical Neoplasia (2018) (19)
- Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancer. (2011) (19)
- Identification of B-epitopes in the human papillomavirus 18 E7 open reading frame protein. (1990) (19)
- Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions (2017) (19)
- The hygromycin-resistance-encoding gene as a selection marker for vaccinia virus recombinants. (1991) (18)
- Single-cell RNA sequencing reveals cell type-specific HPV expression in hyperplastic skin lesions. (2019) (18)
- HPV16E7-Induced Hyperplasia Promotes CXCL9/10 Expression and Induces CXCR3+ T-Cell Migration to Skin. (2017) (18)
- An Ex Vivo Human Tumor Assay Shows Distinct Patterns of EGFR Trafficking in Squamous Cell Carcinoma Correlating to Therapeutic Outcomes. (2019) (18)
- Clinical development strategy for a candidate group A streptococcal vaccine. (2017) (18)
- The role of the immune system in anogenital human papillomavirus. (1998) (18)
- No Vacillation on HPV Vaccination (2018) (18)
- Batf3 selectively determines acquisition of CD8+ dendritic cell phenotype and function (2016) (18)
- Calcium enhances mouse keratinocyte differentiation in vitro to differentially regulate expression of papillomavirus authentic and codon modified L1 genes. (2007) (18)
- A Combination of Local Inflammation and Central Memory T Cells Potentiates Immunotherapy in the Skin (2012) (18)
- Clinically-Relevant Rapamycin Treatment Regimens Enhance CD8+ Effector Memory T Cell Function In The Skin and Allow their Infiltration into Cutaneous Squamous Cell Carcinoma (2018) (17)
- Hpv Dna In Oropharyngeal Squamous Cell Cancers: Comparison of Results from Four DNA Detection Methods (1993) (17)
- Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma (2020) (17)
- The Kinematics of Cytotoxic Lymphocytes Influence Their Ability to Kill Target Cells (2014) (17)
- Prevalence of Cervical Human Papillomavirus (HPV) Infection in Vanuatu (2012) (17)
- Antigen-specific CD4 cells assist CD8 T-effector cells in eliminating keratinocytes. (2010) (17)
- Antibody to G-actin in different categories of alcoholic liver disease: quantification by an ELISA and significance for alcoholic cirrhosis. (1985) (17)
- Influence of human immunodeficiency virus antibody testing on sexual behaviour in a “high‐risk” population from a “low‐risk” city (1988) (16)
- Detection of HPV E7 Transcription at Single-Cell Resolution in Epidermis. (2018) (16)
- Increasing mechanical stimulus induces migration of Langerhans cells and impairs the immune response to intracutaneously delivered antigen (2011) (16)
- Expression of papillomavirus L1 proteins regulated by authentic gene codon usage is favoured in G2/M-like cells in differentiating keratinocytes. (2010) (16)
- HPV vaccination: what do Queensland parents think? (2007) (16)
- A randomized trial of immunotherapy for persistent genital warts (2012) (16)
- AIDS‐associated psoriasis responds to azidothymidine (1988) (16)
- An ELISA capture assay for the E7 transforming proteins of HPV16 and HPV18. (1992) (15)
- Scavenging of soluble and immobilized CCL21 by ACKR4 regulates peripheral dendritic cell emigration (2021) (15)
- Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia. (2019) (14)
- A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC) (2020) (14)
- Autoimmunity and persistent viral infection: two sides of the same coin? (2008) (14)
- Depressed activities of purine enzymes in lymphocytes of patients infected with human immunodeficiency virus. (1989) (13)
- Genomewide scans of red cell indices suggest linkage on chromosome 6q23 (2006) (13)
- Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis (2007) (13)
- Safety and Immunogenicity of HPV16 E7/Algammulin (1999) (13)
- High‐risk human papillomavirus detection in oropharyngeal cancers: Comparison of saliva sampling methods (2019) (13)
- Cerebral dysfunction with evidence of cerebral HIV infection amongst asymptomatic HIV seropositive subjects. (1989) (12)
- Dysregulation of Stemness Pathways in HPV Mediated Cervical Malignant Transformation Identifies Potential Oncotherapy Targets (2020) (12)
- Cervical cancer vaccine development. (2010) (12)
- Post translational modifications of recombinant human papillomavirus type 6b major capsid protein. (1999) (12)
- Up-regulated expression of Sp1 protein coincident with a viral protein in human and mouse differentiating keratinocytes may act as a cell differentiation marker. (2008) (11)
- Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study (2014) (11)
- T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16. (1999) (11)
- Finding a vaccine for human papillomavirus (2006) (11)
- Spontaneous reverse hemolytic plaque formation. III. Monocyte-mediated suppression of elevated plaque formation in autoimmune disease. (1982) (11)
- HPV16-E7 Expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesions (2014) (10)
- Lymphocyte ectoenzyme activity compared in healthy persons and patients seropositive to or at high risk of HIV infection (1990) (10)
- Immunology of Anogenital Human Papillomavirus (HPV) Infection (1990) (10)
- Cytokine/chemokine profiles in squamous cell carcinoma correlate with precancerous and cancerous disease stage (2019) (10)
- Interleukin-17A Promotes Arginase-1 Production and 2,4-Dinitrochlorobenzene-Induced Acute Hyperinflammation in Human Papillomavirus E7 Oncoprotein-Expressing Skin (2015) (10)
- Effects of additional sequences directly downstream from the AUG on the expression of GFP gene. (2003) (10)
- Strategies for immunoprophylaxis and immunotherapy of papillomaviruses. (1997) (10)
- Examining the contribution of smoking and HPV towards the etiology of oral cavity squamous cell carcinoma using high-throughput sequencing: A prospective observational study (2018) (10)
- Serologic response to human papillomavirus 16 among Australian women with high‐grade cervical intraepithelial neoplasia (2006) (10)
- Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays. (1986) (9)
- Salivary High-Risk Human Papillomavirus DNA as a Biomarker for Human Papillomavirus-Driven Head and Neck Cancers. (2021) (9)
- Erratum: Cervical cancer control, priorities and new directions (International Journal of Cancer (2003) 108 (329-333)) (2004) (9)
- Keratinocytes efficiently process endogenous antigens for cytotoxic T‐cell mediated lysis (2009) (9)
- Manganese-Doped Silica-Based Nanoparticles Promote the Efficacy of Antigen-Specific Immunotherapy (2021) (9)
- HPV immunisation: a significant advance in cancer control. (2007) (9)
- Expression of the HPV16E7 Oncoprotein by Thymic Epithelium is Accompanied by Disrupted T Cell Maturation and a Failure of the Thymus to Involute with Age (2003) (9)
- Secreted Toxins From Staphylococcus aureus Strains Isolated From Keratinocyte Skin Cancers Mediate Pro-tumorigenic Inflammatory Responses in the Skin (2022) (9)
- Human growth hormone presented by K14hGH‐transgenic skin grafts induces a strong immune response but no graft rejection (2004) (9)
- B cell chronic lymphocytic leukaemia cells have reduced capacity to upregulate expression of MHC class I in response to interferon‐γ (2004) (9)
- Male partners of women with genital human papillomavirus infection: An assessment of colposcopic abnormalities by histological examination and human papillomavirus hybridization (1989) (8)
- Changes to peptide structure, not concentration, contribute to expansion of the lowest avidity cytotoxic T lymphocytes (2004) (8)
- CD8+ lineage dendritic cells determine adaptive immune responses to inflammasome activation upon sterile skin injury (2018) (8)
- The HPV Vaccine Story. (2019) (8)
- Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules (2019) (8)
- IL‐1 signalling determines the fate of skin grafts expressing non‐self protein in keratinocytes (2009) (8)
- Capture ElISA and in vitro cell binding assay for the detection of antibodies to human papillomavirus type 6b virus-like particles in patients with anogenital warts. (1999) (8)
- Antibodies to liver cell membrane antigens in chronic active hepatitis (CAH). III. Partial characterization of the liver cell membrane antigens and comparison of reactivities in sera from patients with various liver diseases. (1984) (8)
- HPV16-E7-Specific Activated CD8 T Cells in E7 Transgenic Skin and Skin Grafts (2017) (8)
- CHAPTER 8 HPV vaccines (2006) (8)
- Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC‐1 tumor‐bearing mice with PD‐1 blockade by modulating macrophage heterogeneity and the activation of CD8+ T cells in the tumor microenvironment (2021) (8)
- Absence of Batf3 reveals a new dimension of cell state heterogeneity within conventional dendritic cells (2021) (8)
- Low level expression of human papillomavirus type 16 (HPV16) E6 in squamous epithelium does not elicit E6 specific B- or T-helper immunological responses, or influence the outcome of immunisation with E6 protein. (2001) (7)
- Section review: Biologicals & immunologicals: Human papillomavirus infection, genital warts and cervical cancer: Prospects for prophylactic and therapeutic vaccines (1995) (7)
- Developmental Genetics of Red Cell Indices During Puberty: A Longitudinal Twin Study (2001) (7)
- Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients (2021) (7)
- Recruitment of Antigen Presenting Cells to Skin Draining Lymph Node From HPV16E7-Expressing Skin Requires E7-Rb Interaction (2018) (7)
- Re: Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. (2001) (6)
- T Cell-Mediated and Non-Specific Inflammatory Mechanisms Contribute to the Skin Pathology of HPV 16 E6E7 Transgenic Mice (1999) (6)
- Simplifying the molecular mechanisms of human papillomavirus. (1998) (6)
- TITLE: HPV16 E7-driven epithelial hyperplasia promotes impaired antigen presentation and regulatory T cell development. (2019) (6)
- Collaboration in the War against Viruses: A Multidisciplinary International Effort (2020) (6)
- The early monocytic response to cytomegalovirus infection is MyD88 dependent but occurs independently of common inflammatory cytokine signals (2014) (6)
- The molecular specificity of linear B-epitopes in the E7 open reading frame protein of human papillomavirus 16 defined by monoclonal antibodies. (1990) (6)
- Immunotherapy for HPV associated pre-cancer (2003) (5)
- Antigen-specific CD8 T cells can eliminate antigen-bearing keratinocytes with clonogenic potential via an IFN-gamma-dependent mechanism. (2010) (5)
- Human papillomavirus E7 oncoprotein expression by keratinocytes alters the cytotoxic mechanisms used by CD8 T cells (2017) (5)
- Antibody-Free Multiplex Measurement of 23 Human Cytokines in Primary Cell Culture Secretome Using Targeted Mass Spectrometry. (2020) (5)
- Changes in the skin microbiome associated with squamous cell carcinoma in transplant recipients (2022) (5)
- Papovaviridiae: capsid structure and capsid protein function (1996) (5)
- Efficiency of delivery of DNA to cells by bovine papillomavirus type-1 L1/L2 pseudovirions (2001) (5)
- A model of impaired Langerhans cell maturation associated with HPV induced epithelial hyperplasia (2021) (4)
- A neonatally tolerant mouse model to assess pathogenicity of human autoantibodies. (1990) (4)
- Vaccines against virally induced cancers (1994) (4)
- The actinic keratosis virome: can we prevent squamous cell carcinoma with a vaccine? (2015) (4)
- THERAPEUTIC VACCINATION AGAINST CERVICAL CANCER - ARE WE NEAR? (2008) (4)
- Immunology of HPV infection (1999) (4)
- Eradicating HPV-Associated Cancer Through Immunization: A Glass Half Full…. (2018) (4)
- Advances in Brief Antigen-specific CD 4 T-Cell Help Is Required to Activate a Memory CD 8 T Cell to a Fully Functional Tumor Killer Cell 1 (2002) (4)
- Correction: Defining the genetic susceptibility to cervical neoplasia—A genome-wide association study (2018) (4)
- Skin Cancer-Associated S. aureus Strains Can Induce DNA Damage in Human Keratinocytes by Downregulating DNA Repair and Promoting Oxidative Stress (2022) (4)
- Cortisol changes interact with the effects of a cognitive behavioural psychological preparation for surgery on 12-month outcomes for surgical heart patients (2009) (4)
- CD4+CD8β+ double‐positive T cells in skin‐draining lymph nodes respond to inflammatory signals from the skin (2017) (4)
- A Biometrical View on Normal Values of CD4 and CD8 Lymphocyte Counts in Peripheral Blood (1988) (4)
- Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method (2020) (4)
- Importance of human papillomavirus infection in squamous cell carcinomas of the tongue in Guangdong Province, China (2020) (4)
- The role of the immune system in human papillomavirus infection (1998) (3)
- How HIV promotes malignancies (1996) (3)
- Immune responses to liver-specific lipoprotein and liver membrane antigen: a tabular interpretative review. (1984) (3)
- BRIEF COMMUNICATION—A GRAPHICAL PRESENTATION OF COUNTS OF T LYMPHOCYTE SUBPOPULATIONS AND TH‐TS RATIOS (1985) (3)
- Immunology of Papillomavirus Infection of the Human Anogenital Epithelium (1990) (3)
- [Immunogenicity study of HPV 6b virus-like particles]. (2002) (3)
- Autoantibodies, sheep cell agglutinins and anti-albumin antibodies in alcoholic liver disease. (1984) (3)
- Cancer vaccines (2022) (3)
- Construction and production of fluorescent papillomavirus-like particles (2008) (3)
- Tumour susceptibility to innate and adaptive immunotherapy changes during tumour maturation (2004) (3)
- IFN-γ Critically Enables the Intratumoural Infiltration of CXCR3+ CD8+ T Cells to Drive Squamous Cell Carcinoma Regression (2021) (3)
- Identification of Immune Effector-Cells in the Liver of Patients with Chronic Active Hepatitis Using Monoclonal Antisera (1983) (2)
- A rapid micromethod for evaluating T cell subsets in blood using monoclonal antisera. (1983) (2)
- Antigen Nonspecific Induction of Distinct Regulatory T Cell States in Oncogene-Driven Hyperproliferative Skin (2021) (2)
- Multiple Conformational Epitopes Are Recognized by Natural and Induced Immunity to the E7 Protein of Human Papilloma Virus Type 16 in Man (2000) (2)
- Immunoregulatory defects associated with infection with the AIDS virus, HTLV-III. (1987) (2)
- Humoral immune response to the E7 open reading frame protein of human papillomavirus genotype 16 in subjects with anogenital papillomavirus infection and controls (1992) (2)
- Vaccines to Prevent and Treat Human Papillomavirus‐Associated Anogenital Disease (2007) (2)
- Precursors of Cervical-Cancer - the Male Factor (1993) (2)
- Analysis of human leukocyte antigen associations in human papillomavirus–positive and –negative head and neck cancer: Comparison with cervical cancer (2022) (2)
- Vaccines against human papillomaviruses (2010) (2)
- Determining the utility of a screening program to reduce the incidence of HPV driven oropharyngeal cancer (2021) (1)
- Use of Double Aro Salmonella Mutants to Stably Express HPV16 E7 Protein Epitopes Carried by HBV Core Antigen (1994) (1)
- Regulatory T-cells but not IL-10 impair cell-mediated immunity in HPV+ hyperplastic epithelium. (2020) (1)
- Towards the development of edible vaccines for human papillomavirus in bananas (2001) (1)
- An update on cervical cancer screening in Vanuatu (2020) (1)
- Response to Comment on “Invariant NKT Cells in Hyperplastic Skin Induced a Local Immune Suppressive Environment by IFN-γ Production” (2012) (1)
- Editorial: Immunology of HPV Infection and Vaccination: Progress and Challenges (2021) (1)
- Vaccines against human papillomavirus infection (2004) (1)
- Autoantibodies to liver antigens in chronic liver disease. I. A radioimmunoassay for antibody to liver membrane antigens. (1982) (1)
- The two faces of human papillomavirus. (2010) (1)
- Is vaccine therapy the future in cancer prevention? (2004) (1)
- Routine HIV testing before surgery. (1995) (1)
- Prevention of cervical cancer through vaccination (2014) (1)
- Functional memory CD8+ T cells can be generated in vivo without evident T help. (2004) (1)
- Predictors of genital warts among women attending two family planning clinics. (2000) (1)
- Acquisition of murine splenic myeloid cells for protein and gene expression profiling by advanced flow cytometry and CITE-seq (2021) (1)
- Managing HIV. Part 3: Mechanisms of disease. 3.6 How HIV promotes malignancies. (1996) (1)
- Environmental pathways affecting gene expression (E.PAGE) as an R package to predict gene–environment associations (2022) (1)
- Repurposing of Commercially Existing Molecular Target Therapies to Boost the Clinical Efficacy of Immune Checkpoint Blockade (2022) (1)
- Antibodies to Liver Membrane-Antigens in Chronic Liver-Disease (1983) (1)
- Pre-malignant immune suppressive environment is dependent on HPV16E7-Rb interaction induced epithelium hyperplasia (2016) (1)
- Immunotherapy for cancer: progress at a cost we can afford? (2016) (0)
- Small Synthetic Peptides as Vaccines - a Model Peptide Iscom Construct From Cancer-Associated Human Papillomavirus (1994) (0)
- Interferon-gamma is required for killing keratinocytes in vitro and in vivo (2005) (0)
- Hpv16 E7 Transgenic Skin Is Not Rejected in E7 Immunized Mice (1995) (0)
- Delivering Papillomavirus Vaccines When and Where They’re Most Needed (2006) (0)
- Vaccine delivery: Nanopatch-Targeted Skin Vaccination against West Nile Virus and Chikungunya Virus in Mice (Small 16/2010) (2010) (0)
- Autoimmune neurological disease: Antigen recognition and self–non-self discrimination (1995) (0)
- Rapamycin, but not tacrolimus, promotes Cd8 memory T-cell differentiation and function in the skin (2016) (0)
- in a Primed Host Response to a Novel Viral Epitope g Cell IFN-IL-10 Mediates Suppression of the CD8 T (2003) (0)
- Simplifying the molecular mechanisms of human papillomavirus : Sexually transmitted diseases (1998) (0)
- Geneti c and envi r onmental causes of var i ati on i n basal l evel s of bl ood cel l s (2007) (0)
- E.PAGE: A curated database and enrichment tool to predict gene modules associated with gene-environment interactions (2022) (0)
- A novel Nanopatch that directly delivers influenza vaccine painlessly to antigen presenting cells in the skin and affords high dose reduction (2009) (0)
- Absence ofautoimmune serological reactions in chronic nonA,nonBviral hepatitis (1985) (0)
- Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future therapies? (2023) (0)
- HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer (2022) (0)
- A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16INK4a expression in head and neck squamous cell carcinoma patients (2016) (0)
- Betel-associated Oral Cancers from Papua New Guinea Are Infrequent in p 53 Mutations in the Conserved Regions of Updated (2016) (0)
- Overcoming original antigenic sin to generate effective immune responses in antigen primed host (2005) (0)
- Correction: The Kinematics of Cytotoxic Lymphocytes Influence Their Ability to Kill Target Cells (2014) (0)
- Supplementary Material for: Interleukin-17A Promotes Arginase-1 Production and 2,4-Dinitrochlorobenzene-Induced Acute Hyperinflammation in Human Papillomavirus E7 Oncoprotein-Expressing Skin (2017) (0)
- Apoptosis mediated by CD8+T cells targeted to endogenous antigens in transgenic keratinocytes (2005) (0)
- Abstract A47: Increased levels of IL-12, IL-23 and IL-18 in skin expressing HPV16 E7 protein. (2013) (0)
- Vaccines to prevent and treat cervical cancer (2002) (0)
- 2125. Staphylococcus Species Identification by Fourier Transform Infrared (FTIR) Spectroscopic Techniques: A Cross-Lab Study (2019) (0)
- Abstract B055: The impact of rapamycin and tacrolimus treatment on resident CD8+ T-cell populations in cutaneous squamous cell carcinoma (2016) (0)
- Wart and hepatitis vaccines (2002) (0)
- Microprojection arrays applied to skin generate mechanical stress, induce an inflammatory transcriptome and cell death, and improve vaccine-induced immune responses (2019) (0)
- Mucosal and systemic immunization with BPVL1E7VLP vaccine induce effective cellular immunity (2001) (0)
- A model of peripheral CD8(+) T cell tolerance against skin antigen (2005) (0)
- Regulatory T Cells but Not IL-10 Impair Cell-Mediated Immunity in Human Papillomavirus E7 D Hyperplastic Epithelium (2021) (0)
- Single-dose HPV vaccine immunity: is there a role for non-neutralizing antibodies? (2022) (0)
- Uncovering novel regulators of CD8(+) T-cell functions in the skin (2016) (0)
- Adjuvants Can Bias to Th1 or Th2 the Immune-Response to Hpv E7 Protein in Mice (1993) (0)
- Observation of human papilloma type 6 VLPs in insect cells (1994) (0)
- Symposium On Vaccines Against Virally Induced Cancers, Held At the Ciba-Foundation, London, 15-17-March-1994 - Introduction (1994) (0)
- E6, E7 and VLP based papillomavirus vaccines for prevention of Cervical cancer (2004) (0)
- Gardasil HPV Vaccination Series [1] (2021) (0)
- Immunotherapy for persisting viral infection and associated cancer (2016) (0)
- A phase 1b multicentre study of HPV6 L1 virus-like particles as adjunct immunotherapy for anogenital warts (2009) (0)
- Interferon-gamma, but not perforin or FasL, is required for killing keratinocytes in vitro and in vivo (2005) (0)
- Fundamental and applied aspects of rheumatoid arthritis (1983) (0)
- CD4+ CD8+ double-positive T-cells regulate CD8+ single-positive T cell function in the skin (2016) (0)
- An Improved Immunoassay for the E7 Protein of Hpv16 (1993) (0)
- Quantitative trait loci underlying variation in blood cell concentrations (2001) (0)
- The Innovation: A Journal to See the Unseen and Change the Unchanged (2020) (0)
- Radioimmunoassay for Antibody to Liver Membrane Antigen Using Isolated Monkey Hepatocytes (1982) (0)
- Serologic response to human papillomavirus 16 among Australian women with high-grade cervical intraepithelial neoplasia (2005) (0)
- Development of immunotherapeutic immunizations for virus infections and cancer (2016) (0)
- The involvement of IFN-gamma and CXCR3 in the CD8(+) T-cell-mediated regression of squamous cell carcinoma (2019) (0)
- Vaccination to prevent cervical cancer: a dream turned reality, with a twist in the tail (2007) (0)
- DepressedActivities of Purine Enzymesin Lymphocytesof Patients Infected with Human ImmunodeficiencyVirus (1989) (0)
- Expression of HPV16-E7 oncoprotein in skin exacerbates the contact hypersensitivity response to DNCB (2012) (0)
- A Transgenic Mouse Model of the Immunobiology of Hpv16 Induced Cervical-Cancer (1994) (0)
- Ian Hector Frazer (1953– ) (2020) (0)
- Not Perforin or Fas-L, is Required for Killing Keratinocytes In Vitro and In Vivo (2005) (0)
- Deep spatial-omics to aid personalization of precision medicine in metastatic recurrent Head & Neck Cancers (2023) (0)
- Abstract 3999: Altering the balance between immune activation versus regulation in the skin to promote CD8 T-cell activity within epithelial cancers (2016) (0)
- Caerin 1.1/1.9 Enhances Antitumour Immunity by Activating the IFN-α Response Signalling Pathway of Tumour Macrophages (2022) (0)
- Vaccines for papilloma v irus infection (2002) (0)
- Antigen Presentation as a Determinant of the Outcome of Papillomavirus Infection (1993) (0)
- Controlling Hpv Associated Disease: a Glass Half Full? (2009) (0)
- Interference with Wnt pathway improves host control of Listeria monocytogenes in vivo (2014) (0)
- HPV 6b L1 virus-like particles elicit humoral immunity in mice (2003) (0)
- The future of HPV vaccination (2015) (0)
- States in Oncogene-Driven Hyperproliferative Skin Antigen Nonspecific Induction of Distinct Regulatory T Cell (2021) (0)
- Erratum: IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host (Journal of Immunology (2003) 171 (4765-4772)) (2004) (0)
- Cancer Immunotherapy in the 21St Century (2012) (0)
- Antibodies toliver cell membrane antigens inchronic active hepatitis (CAH). III. Partial characterization ofthe liver cell membrane antigens andcomparison ofreactivities inserafrompatients withvarious liver diseases (1984) (0)
- The Greg Johnson memorial oration. Translational research in new areas: Lessons from papillomavirus immunotherapy (2007) (0)
- The role of CD4 T help in multiple vaccinations when using minimal CD8 T cell epitope peptides (2005) (0)
- Production g Environment by IFN-Induce a Local Immune Suppressive Invariant NKT Cells in Hyperplastic Skin (2009) (0)
- Presence of Skin Disease E 6 / E 7-transgenic Mice to E 7 Protein Correlate with the Immunological Responses in Human Papillomavirus 16 Updated (2006) (0)
- 1 RNA-seq reveals more consistent reference genes for gene expression studies in human 2 non-melanoma skin cancers 3 (2019) (0)
- HARNESSING THE IMMUNE SYSTEM TO PREVENT CERVICAL CANCER (2006) (0)
- Exhausted T cell signature enriched in HPV16 E7 mouse model and cervical intraepithelial neoplasia grade III (2016) (0)
- Use of Recombinant Hepatitis-B Core Antigen Particles to Deliver Hpv16-E7 Immunogenic Signals (1993) (0)
- Signals at the Time of First Antigen Exposure Determined by Systemic Proinflammatory Expressed in Somatic Cells Can Be Tolerance or Immunity to a Tumor Antigen (2001) (0)
- Tumor Model Suppress Antitumor CTL Activity in a Mouse Cells Neither Enhance nor + Th2-Type CD4 (1998) (0)
- Progress in cancer control: the Alan Coates effect (2006) (0)
- Intra-tumoral injection of caerin 1.1 and 1.9 peptides in vaccinated TC-1 tumour bearing mice with PD-1 blockade modulates macrophage heterogeneity and the activation of CD8+ T cells in the tumour microenvironment (2020) (0)
- Trafficking of E7 specific CD8 T cells from the host to hyperproliferative graft (2016) (0)
- KL Vaccines against stis: where have we got to? (2015) (0)
- PROTEINS OF KERATIN AND THEIR SYNTHESIS. II. INCORPORATION OF [$sup 35$S] CYSTINE INTO PREKERATIN AND KERATIN PROTEINS. (1969) (0)
- CD1d/NKT cells (WS-006) Chairpersons: Ken-ichiro Seino, Dale Godfrey (2010) (0)
- Systemic lymphopenia results in loss of suppressive lymphocytes from precancerous skin (P2081) (2013) (0)
- Localized granulomatous epiglottitis (1993) (0)
- Development of a Vaccine Against Human Papillomavirus (HPV (2005) (0)
- Epithelial Hyperplasia in Human Papillomavirus-Associated IL-17 Suppresses Immune Effector Functions (2014) (0)
- Abstract A064: Modeling checkpoint blockade inhibitor resistant immunoregulation induced by squamous epithelial cancers (2016) (0)
- Transgenic expression of a viral oncoprotein exclusively in K14(+) epithelial cells results in peripheral but not central CD8 T cell tolerance (2005) (0)
- MEDICAL ONCOLOGY GROUP OF AUSTRALIA PIERRE FABRE CANCER ACHIEVEMENT AWARD * Papillomavirus specific immunity as a means to prevent deaths from cervical cancer (2007) (0)
- Zhonghua Yixuezazhi (National Medical Journal of China) (2002) (0)
- A rapid micromethod for the enumeration of T cell subsets in blood by epifluorescence microscopy. (1986) (0)
- Infections. VII, Anogenital HPV infections treating the lesions in both partners (1991) (0)
This paper list is powered by the following services:
Other Resources About Ian Frazer
What Schools Are Affiliated With Ian Frazer?
Ian Frazer is affiliated with the following schools:
